Korean J Thorac Cardiovasc Surg.  1997 Mar;30(3):247-252.

Development and Animal Tests of Pneumatic Ventricular Assist Device

Affiliations
  • 1Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Korea.
  • 2Cardiovascular Research Institute, Yonsei University College of Medicine, Korea.

Abstract

Ten acute and chronic in vivo studies were utilized to develop a pneumatic ventricular assist device(VAD) as a bridge to heart transplantation or a circulatory assist device for patients with end-stage heart disease or poor myocardial function after cardiac surgery. Two sizes of blood pump of 70cc for adult patients and 34cc for pediatric patients were implanted in the animals. Ventricle of the blood pump was made from the polyurethane to enhance antithrombogenecity. The VAD was implanted between the left atrium and the descending aorta. Average flow rate was 2.38 L/min for adult and 0.41 L/min for pediatric VAD at the rate of 60 bpm. The duration of support ranged from 1 to 26 hours. The most frequent complication was bleeding. Main causes of death were heart failure and respiratory failure. The device function was good for short term use. Studies to date suggest that, with further refinement, a reliable long term VAD that will have clinical application can be developed.

Keyword

Ventricular assist device

MeSH Terms

Adult
Animals*
Aorta, Thoracic
Cause of Death
Heart Atria
Heart Diseases
Heart Failure
Heart Transplantation
Heart-Assist Devices*
Hemorrhage
Humans
Polyurethanes
Respiratory Insufficiency
Thoracic Surgery
Polyurethanes
Full Text Links
  • KJTCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error